Literature DB >> 12781442

Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study.

Christine Pérot1, Liliane Boccon-Gibod, Raymonde Bouvier, François Doz, Jean-Christophe Fournet, Paul Fréneaux, Annick Vieillefond, Jérôme Couturier.   

Abstract

Two cases of renal cell carcinoma (RCC) carrying a t(X;1)(p11.2;q21) in a 12-year-old boy and a 14 year-old girl, two cases with a t(X;1)(p11.2;p34) in a 9-year-old boy and a 31-year-old woman, and one case with a t(X;17)(p11.2;q25) in a 15-year-old boy are reported. Two are likely papillary RCC, with clear or slightly eosinophilic cells, and two to a clear cell RCC; one shows a mixture of papillary and clear cell RCC architecture. Renal cell carcinomas with translocations involving Xp11.2 form a specific entity characterized by subtle pathologic features and younger age of occurrence, especially for those with the t(X;17).

Entities:  

Mesh:

Year:  2003        PMID: 12781442     DOI: 10.1016/s0165-4608(02)00851-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

2.  PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.

Authors:  Ali Mirza Onder; Uygar Teomete; Pedram Argani; Stuart Toledano; Gaston Zilleruelo; Maria M Rodriguez
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

3.  Response to sorafenib in a patient with metastatic xp11 translocation renal cell carcinoma.

Authors:  Ming-Mo Hou; Jia-Juan Hsieh; Nai-Jen Chang; Hsuan-Ying Huang; Hung-Ming Wang; Cheng-Keng Chuang; Todd Hsu; John Wen-Cheng Chang
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature.

Authors:  Jigarkumar Parikh; Teresa Coleman; Nidia Messias; James Brown
Journal:  Rare Tumors       Date:  2009-12-28

5.  TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature.

Authors:  T Nelius; I Al-Khalil; J Vordermark; K Rinard-Holden; T Cammack; V Mamlok; S Filleur
Journal:  Case Rep Med       Date:  2011-10-05

6.  Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.

Authors:  Renhua Song; Qian Liu; Gyorgy Hutvagner; Hung Nguyen; Kotagiri Ramamohanarao; Limsoon Wong; Jinyan Li
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.